- Home
- QNCX vs BRIA Comparison
QNCX vs BRIA Comparison
Compare QNCX & BRIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- BRIA
- Stock Information
- Founded
- QNCX 2012
- BRIA 2011
- Country
- QNCX United States
- BRIA Singapore
- Employees
- QNCX N/A
- BRIA N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- BRIA
- Sector
- QNCX Health Care
- BRIA
- Exchange
- QNCX Nasdaq
- BRIA NYSE
- Market Cap
- QNCX 47.7M
- BRIA 58.5M
- IPO Year
- QNCX 2019
- BRIA 2024
- Fundamental
- Price
- QNCX $1.64
- BRIA $2.30
- Analyst Decision
- QNCX Strong Buy
- BRIA
- Analyst Count
- QNCX 5
- BRIA 0
- Target Price
- QNCX $8.00
- BRIA N/A
- AVG Volume (30 Days)
- QNCX 323.8K
- BRIA 5.3K
- Earning Date
- QNCX 08-12-2025
- BRIA 08-15-2025
- Dividend Yield
- QNCX N/A
- BRIA N/A
- EPS Growth
- QNCX N/A
- BRIA N/A
- EPS
- QNCX N/A
- BRIA 92.24
- Revenue
- QNCX N/A
- BRIA $59,695,825.00
- Revenue This Year
- QNCX N/A
- BRIA N/A
- Revenue Next Year
- QNCX N/A
- BRIA N/A
- P/E Ratio
- QNCX N/A
- BRIA $0.02
- Revenue Growth
- QNCX N/A
- BRIA 8.03
- 52 Week Low
- QNCX $0.51
- BRIA $1.78
- 52 Week High
- QNCX $2.45
- BRIA $4.38
- Technical
- Relative Strength Index (RSI)
- QNCX 65.33
- BRIA N/A
- Support Level
- QNCX $1.29
- BRIA N/A
- Resistance Level
- QNCX $1.62
- BRIA N/A
- Average True Range (ATR)
- QNCX 0.11
- BRIA 0.00
- MACD
- QNCX 0.03
- BRIA 0.00
- Stochastic Oscillator
- QNCX 74.47
- BRIA 0.00
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About BRIA BRILLIA INC
BrilliA Inc is engaged in business of sales and marketing of lingerie's products including bra, panty and body suit, mainly serving the American, European and other markets.